Articles

Editorial

10.4244/EIJ-E-25-00018 Jun 2, 2025
Using pericoronary fat attenuation to guide management after coronary interventions
Antoniades C, Chan K
free

Editorial

10.4244/EIJ-E-25-00014 Jun 2, 2025
Polymer-free biolimus-eluting stents: there is no such thing as a free lunch
Piccolo R, Spitzer E
free

Expert consensus

10.4244/EIJ-D-24-00954 Jun 2, 2025
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
Nielsen-Kudsk J, Aminian A, Backer O, Iriart X, Berti S, Galea R, Freixa X, Räber L, Cruz-González I, Wunderlich N, Garot P
free

Original Research

10.4244/EIJ-D-24-00971 Jun 2, 2025
Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention
Naniwa S, Kawamori H, Toba T, Hiromasa T, Sugizaki Y, Sasaki S, Fujii H, Hamana T, Osumi Y, Yamamoto T, Iwane S, Sakamoto Y, Matsuhama K, Fukuishi Y, Tsunamoto H, Higuchi K, Okamoto H, Iwasaki M, Takaya T, Yamada S, Hirata K, Otake H

Original Research

10.4244/EIJ-D-24-00586 Jun 2, 2025
Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent
Jensen L, Jakobsen L, Eftekhari A, Ellert-Gregersen J, Støttrup N, Engstrøm T, Kahlert J, Freeman P, Veien K, Jensen R, Lassen J, Junker A, Christiansen E

Original Research

10.4244/EIJ-D-24-00763 Jun 2, 2025
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial
Støttrup N, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, Thim T, Jakobsen L, Jensen R, Eftekhari A, Freeman P, Jensen S, Veien K, Jensen L, Maeng M, for Randomized Trials with Clinical Outcome (SORT OUT) ftSO

Editorial

10.4244/EIJ-E-25-00023 May 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T, Cayla G
free

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y, Park S-D, Lee JP, Choi SH, Kong MG, Won YS, Kim M, Lee KH, Han SH, Kwon SW, Suh J, Kang WC
open access

Research Correspondence

10.4244/EIJ-D-25-00396 May 21, 2025
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study
Haude M, Wlodarczak A, van der Schaaf R, Torzewski J, Ferdinande B, Escaned J, Iglesias J, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R
free

Research Correspondence

10.4244/EIJ-D-24-01048 May 21, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y, Ordoñez S, Chu M, Valdis M, Molloy S, Abbadi M, Teefy P, Diamantouros P, Bagur R

Expert consensus

10.4244/EIJ-D-24-01126 May 20, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women
Baron S, Chou J, Shah T, Vest A, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick A, Chieffo A, van Geuns R, Grines C, Halvorsen S, Hassager C, Kapur N, Naidu S, Ng V, Saw J, Lansky A
open access

Expert consensus

10.4244/EIJ-D-24-00876 May 20, 2025
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Paradies V, Masiero G, Rubboli A, van Beusekom H, Costa F, Capranzano P, Degrauwe S, Gorog D, Jorge C, Buchanan G, Alasnag M, Trabattoni D, Fraccaro C, Sibbing D, Dudek D, Vilahur G, Chieffo A, Mehran R, Capodanno D, Barbato E, Siller-Matula J
open access

Editorial

10.4244/EIJ-E-25-00015 May 16, 2025
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome
Watanabe H, Kimura T
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved